Czechs bring in HPV (human papilloma virus) testing
This article was originally published in Clinica
Executive Summary
The Czech Republic has become the first European country to introduce legislation bringing in human papilloma virus testing as a primary screening test for the prevention of cervical cancer. The Czech Ministry of Health has decreed that all women aged over 35, and those under 35 who have borderline or low-grade cytology, should be offered primary HPV screening, as part of a national screening programme.
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.